ICardio.ai and SARC MedIQ PACS Partner to Revolutionize Ultrasound Interpretation With AI Tools

Los Angeles, CA — September 9, 2024 — iCardio.ai, an AI startup backed by Cedars-Sinai, and SARC MedIQ have announced a strategic partnership to integrate advanced AI technology into ultrasound imaging. This collaboration aims to enhance the efficiency, accuracy, and speed of ultrasound interpretation.

The partnership will merge iCardio.ai's AI tools with SARC MedIQ's PACS platform. This integration is expected to bring significant improvements to the evaluation and diagnosis of cardiovascular conditions. Both companies see this as a major step forward in healthcare AI, promising better outcomes for clinicians and patients.

"Artificial intelligence is the next frontier in medicine," said Joseph Sokol, CEO of iCardio.ai. "Our partnership will accelerate this transformation and empower clinicians with advanced tools."

Asaad Hakeem, CEO of SARC MedIQ, added, "This partnership enhances our cloud-based platform and provides users with unparalleled insights and efficiencies."

The collaboration aims to accelerate the availability of AI in Cloud PACS and the broader cardiology healthcare industry.